Evaluation of anticonvulsant activity of Tabernaemontana divaricata (Linn) r. br. flower extract

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue 3, 2011, Pages 310-315

  Basavaraj, P ^a   Shivakumar, B S ^b   Shivakumar, H S ^c   Manjunath, V J ^a  

^a TVM College of Pharmacy   (India)

^b Department of Pharmaceutical Chemistry ^*  (India)

^c BLDE University Campus   (India)

Author keywords

GABA; Gabapentin; Strychnine; T. divaricata

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOPYRIDINE; ANTICONVULSIVE AGENT; DIAZEPAM; GABAPENTIN; ISONIAZID; PHENYTOIN; PICROTOXIN; PLANT EXTRACT; STRYCHNINE; TABERNAEMONTANA DIVARICATA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ELECTRIC SHOCK; FLOWER; LOCOMOTION; MOTOR ACTIVITY; MOUSE; NONHUMAN; SCORING SYSTEM; SEDATION; TONIC SEIZURE;

EID: 79960821064     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Goodman and Gilman's. The pharmacological basis of therapeutics. In: James O. McNamara, editors, Pharmacotherapy of the epilepsies 11thed. New York: McGraw- Hill publishers; 2001. p. 501-525.
2. Duraisami R, Srinivasan D, Ramaswamy S. Anticonvulsant activity of bioflavonoid gossypin. Bangaladesh J Pharmacol 2009; 4:51-54.
3. Mattson RH. Drug treatment of partial epilepsy. Adv Neurol 1992; 57:643-650.
4. Gupta YK, Malhotra J. Adenosinergic system as an endogenous anticonvulsant mechanism. J Physilol and Pharmacol 1997; 41:329-343.
5. Kirtikar KR, Basu BD. Indian medicinal plants. Vol-II, Dehra Dun: Bishen Singh Mahendra Pal Singh publishers; 1998. p. 1577-1578.
6. Satyanarayana D, Joshi AB, Chandrashekar KS, Vijayanarayana K. Anti-inflammatory activity of the flowers of Tabernaemontana divaricata (L.) R.BR. Indian drugs 2004; 41(3): 405-407.
7. Chattipakorn S, Pongapanparadorn A, Pratchayasakul W, Pongchaidacha A, Ingkaninan K, Chattipakorn N. Tabernaemontana divaricata extract inhibits neuronal acetylcholinesterase activity in rats. J Ethnopharmacol 2007; 110 (1): 61-68.
8. Walika N, Pornnarin T, Niwat T, Khongsombat. A preliminary study of Tabernaemontana divaricata root extract on amyloid β-peptide 35-25 induced cognitive deficits in mice. J Ethnopharmacol 2010; 130: 122-126.
9. Sawarkar HA, Khadabadi SS, Mankar DM, Farooqui IA, Jagatap NS. Development and biological evaluation of herbal anti-acne gel. Int.J. PharmTech Res 2010; 2 (3): 2028-2031.
10. Priya T Thambi, Bindu K, Sabu MC, Jolly CI. Antioxidant and anti-inflammatory activities of the flowers of Tabernaemontana coronaria (L.) R. BR. Indian J Pharm Sci 2006; 68 (3): 352-355.
11. Sachin J, Avijeet J, Lokesh D, Dutt KR, Deepak Kumar J. Evaluation of anti-fertility activity of Tabernaemontana divaricata (Linn.) R. BR. Nat. Prod. Res 2010; 24 (9): 855-860.
12. Buger GT and Miller CL. Animal care and facilities, in principles and methods of toxicology. 2nd ed. NewYork: Wallace Hayes A, Raven Press Ltd. 1989. p. 527.
13. Khandelwal KR. Practical pharmacognosy. Pune, Nirali Prakashan publisher; 2010. p 23.15-23.20.
14. Kokate CK, Practical pharmacognosy.4th ed. New Delhi: Vallabh Prakashan publisher; 1994. p. 110-116.
15. OECD 2001-guidelines on acute oral toxicity, Environmental health and safety monograph series on testing and adjustment No.423.
16. Goyal RK, Practicals in Pharmacology. 8th ed. Ahmedabad Shah Prakashan publisher; 2008. p.121-122.
17. Mohd Abid HJ, Hrishikeshavan, Mohammed Asad. Pharmacological evaluation of Pachyrrhizus erosus (L) seeds for central nervous system depressant activity. Indian J Physiol Pharmacol 2006; 50: 143-151.
18. Misra AK, Dandiya PC, Kulkarni SK. Anticonvulsant activity of some trimethoxybenzylidene-2-thiohydantion derivatives. Ind J Pharmacol 1973; 5: 449-450.
19. Shirish D, Ambawade, Veena S, Kasture Sanjay B. Anticonvulsant activity of roots and rhizomes of Glycyrrhiza Glabra. Ind J Pharmacol 2002; 34 251-255.
20. Khosala P, Pandhi P. Anticonvulsant effect of nimodipine alone and in combination with diazepam on PTZ induced status epilepticus. Ind J Pharmacol 2001; 33: 208-211.
21. Bhattacharya S K, Sanyal AK. Inhibition of Pentalenetetrazolinduced convulsions in rats by prostaglandin E1: role of brain monoamines. Psychopharmacology 1978; 56: 235-237.
22. Gerhard Vogel H, Wolf gang H. Drug discovery and evaluation pharmacological assays. 2nd ed., New York: Springer-Verlag Berlin Heidelberg publisher; 2002. p. 487-494.
23. Alice AL Alvin JB. Glycine potentiates strychinine-induced convulsions: role of NMDA receptors. J Neurosci 1988; 8 (10): 3823-3826.
24. Curtis DR, Game CJA, Lodge D. Benzodiazepines and central glycine receptors. Br.J. Pharmac 1976; 56: 307-311.
25. Adeyemi OO, Akindele AJ, Yemitan OK, Fagbo FI. Anticonvulsant, anxiolytic and sedative activities of the aqueous root extract of Securidaca longependunculata fresen. J Ehanopharmacol 2010; 130: 191-195.
26. Nandakumar J, Manoj GT. Evaluation of cyclic nucleotide phosphodiesterase III inhibitors in animal models of epilepsy. Biomedical research 2008; 19: 13-17.
27. Veronica BB, Joao BT, Rocha, Vanderlei Folmer. Diphenyl diselenide and diphenyl ditelluride increase the latency for 4- aminopyridine-induced chemical seizure and prevent death in mice. Acta Biochemica Polonica 2009; 56: 125-134.
28. Watts AE, Jefferys JGR. Effects of carbamazeipine and baclofen on 4-aminopyridine-induced epileptic activity in rat hippocampal slices. Br. J. Pharmacol 1993; 10: 819-823.
29. Om Prakash Mishra, Deepak S, Ram SU, Divya A. Cerebrospinal fluid zinc, magnesium, copper and gamma-aminobutyric acid levels in febrile seizures. J Child Neurol 2007; 5: 39-44.
30. Chintawar RS, Somani RS, Veena SK, Kasture SB. Nootropic activity of Albizzia lebbeck in mice. J Ethanopharmacol 2002; 81: 299-305.
31. Maharudra SR, Sanjay RC. Evaluation of CNS depressant activity of momordica dioica (Roxb) wild fruit pulp. Int J Pharm Pharm Sci 2010; 2: 124-126.
32. Wang WP, Iyo AH, Miguel-Hidaglo J, Regunathan S, Zhu MY. Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain research 2006; 1084 (1): 210-216.
33. Yasuyoshi I, Masashi N, Masato Y. Effect of isoniazid on the pharmacodynamics of cefazolin-induced seizures in rats. Drug Metab. Pharmacokinet 2005; 20 (2): 117-120.
34. Thesleff S. Amino pyridines and synaptic transmission. Neurosci 1980; 5 (8): 1413-1419.
35. Rogawski MA, Barker JL. Effects of 4-aminopyridine on calcium action potentials and calcium current under voltage clamp in spinal neurons. Brain Res 1983; 280 (1): 180-185.
36. Morales-Villagrán A, Urena-Guerrero M, Tapia R. Protection by NMDA receptor antagonists against seizures induced by intracerebral administration of 4-aminopyridine. Eur J Pharmacol 1996; 305 (1-3): 87-93.
37. Tapia R, Medina-Ceja L, Pena F. On the relationship between extracellular glutamate, hyperexcitation and neurodegeneration in vivo. Neurochem Int 1999; 34 (1): 23-31.
38. Fragoso-Veloz J, Tapia R. NMDA receptor antagonists protect against seizures and wet-dog shakes induced by 4- aminopyridine. Eur J Pharmacol 1992; 221 (2-3): 275-280.
39. Ramnathan M, Shivakumar S, Anandvijaykumar PR, Saravanababu C, Rathinavel PP. Neuroprotective evaluation of standardised extract of Centella asciatica in monosodium glutamate treated rats. Indian J. Expt. Biol 2007; 45 (5): 425-431.